Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Event Logistics

- PMLiVE

FDA panel fails to back new use for AbbVie’s Humira

Votes 12 to 1 against new use in spondyloarthritis

- PMLiVE

VIDEO: The potential of mHealth for pharma

PMLiVE speaks to Alexandra von Plato, president, global creative officer, Digitas Health at Think Digital 2013

- PMLiVE

Pharma industry announces data sharing commitment

EFPIA and PhRMA agree to make trial info available to qualified researchers

Biogen Idec building

Patient death probably not linked to Biogen Idec’s Tecfidera

Stock recovers after unfounded claims

Roche - Basel

Roche antibody tops Rituxan in blood cancer CLL

Obinutuzumab on course for leukaemia approval by year-end

National Institute for Health and Care Excellence NICE logo

NICE gives final backing to drugs from Bayer, GSK and Otsuka

Eylea, Revolade and Abilify all recommended for NHS use

- PMLiVE

All eyes on pharma in Brazil

With a large population, a growing economy and a well-established healthcare system, Brazil is high on the list for most companies looking to expand into emerging markets.

- PMLiVE

Simbec appoints ex-ABPI DG as chairman

Trevor Jones move to the Wales-based CRO comes as Simbec receives a major cash boost

- PMLiVE

What next in home healthcare?

October conference will hear from Homecare Medicines Review author Mark Hackett and other key stakeholders

Biogen Idec building

Biogen Idec’s long-acting beta interferon moves ahead in MS

US and EU accept filings for long-acting multiple sclerosis drug Plegridy

- PMLiVE

UCB files Vimpat patent claims against 15 companies

Aurobindo, Glenmark, Mylan, Ranbaxy and Sandoz all face legal challenge over generic versions of UCB's epilepsy drug

China flag thumb

AstraZeneca and UCB drawn into Chinese investigations

Follows country’s clampdown on GSK bribery

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links